Reporter cell line Luc/GFP For the purpose of researching gene expression and biological functions, the NCI-N87 cell line was modified to express the luciferase/green fluorescent protein (Luc/GFP) reporter system. The NCI-N87 gastric carcinoma cell line, which is frequently utilized in cancer research, is the source of this cell line.
By measuring GFP fluorescence and luciferase activity, the Luc/GFP reporter system enables real-time monitoring of gene expression and cellular processes. The oxidation of luciferin is catalyzed by the enzyme luciferase, which produces light emission that may be measured with a luminometer. In contrast, GFP exhibits green fluorescence in response to particular light wavelengths, making it possible to observe gene expression in living cells.In 1976, a male patient diagnosed with gastric adenocarcinoma had his stomach opened up, revealing the human gastric cancer cell line NCI-N87. One of the most common malignant tumors in the world is stomach cancer, specifically gastric adenocarcinoma, which is associated with a high death rate and few therapeutic choices. NCI-N87 cells have low positivity for vasoactive intestinal peptide (VIP) receptors, negative dopa decarboxylase (DDC) receptors, lack gastrin receptors, and express the surface glycoproteins carcinoembryonic antigen (CEA) and TAG 72. They also have receptors for cholinergic toxin compounds like colchicine.Under normal cell culture conditions, NCI-N87 cells develop naturally in monolayers and have an epithelial appearance. They are usually grown at 37°C in a humidified environment with 5% CO2 supplemented with growth media including antibiotics and fetal bovine serum.
HER2 is a key driver of tumorigenesis in gastric cancer, and trastuzumab is the primary therapy for HER2-positive patients. However, many patients exhibit resistance to trastuzumab due to insufficient drug sensitivity. In the study, the researchers utilized the NCI-N87/luc cell line to establish tumor xenografts in mice, with treatments including trastuzumab and TFBG. This model allowed for the assessment of SHCBP1's role in drug resistance and the evaluation of combination therapy. At Creative Biogene, our Luc/GFP Reporter Cell Line-NCI-N87 can be used for similar research directions, offering a powerful tool for studying gene expression and cell signaling in gastric cancer and other HER2-related research.
Figure 1. The researchers investigated the effects of SHCBP1 knockdown on trastuzumab sensitivity in gastric cancer cell lines NCI-N87 and SNU-216. They performed cell viability assays, colony formation assays, and in vivo xenograft experiments to assess tumor growth and drug sensitivity. Their results demonstrated that SHCBP1 depletion significantly increased trastuzumab sensitivity both in vitro and in vivo. (Shi W, et al., 2021)
1. Gene expression monitoring: Using the Luc/GFP reporter system, the gene expression level and biological function in NCI-N87 cells are monitored in real time. By measuring GFP fluorescence and luciferase activity, the dynamic changes of gene expression levels and cellular processes can be quantitatively evaluated.
2. Cell function research: Through the Luc/GFP reporter system, the biological characteristics and functions of NCI-N87 cells are deeply studied, and its mechanism of action in the occurrence and development of gastric cancer is explored, providing new ideas and targets for the treatment and prevention of gastric cancer.
3. Live cell imaging: Using GFP fluorescence imaging technology, the spatial distribution and dynamic changes of gene expression in NCI-N87 cells are observed in real time, revealing the biological behavior and subcellular structure of gastric cancer cells.
4. Drug screening and evaluation: With the help of the Luc/GFP reporter system, drug screening and evaluation experiments are carried out to evaluate the effects of candidate drugs on the growth and survival of NCI-N87 cells, providing new methods and approaches for the screening and development of gastric cancer therapeutic drugs.
5. Gastric cancer research: As a commonly used gastric cancer cell line, NCI-N87 cells are of great significance in gastric cancer research. By using the Luc/GFP reporter system, we can deeply explore the pathogenesis, molecular regulatory network and therapeutic targets of gastric cancer, and provide a new scientific basis for clinical treatment of gastric cancer.
Customer Q&As
Luc/GFP Reporter Cell Line-NCI-N87 cell line What are the expression levels of Luciferase and GFP? Is it stable under different culture conditions?
A: Our Luc/GFP Reporter Cell Line-NCI-N87 has undergone rigorous screening and verification to ensure stable expression of Luciferase and GFP genes. We verified the expression levels of both through fluorescence microscopy, flow cytometry, and luciferase activity detection, and conducted repeated tests at different time points and in different batches. Cells can maintain stable expression of Luciferase and GFP under appropriate culture conditions.
What impact does the NCI-N87 background have on the performance of this Reporter cell line? Are special culture conditions required?
A: The impact of the NCI-N87 cell line as a vector on the Luc/GFP Reporter cell line is considered minimal. However, we recommend that customers pay attention to the special growth requirements of the NCI-N87 cell line during use, such as culture medium components and culture conditions, to ensure optimal expression and stability of the cells. We provide detailed training guides to help clients overcome potential issues.
Have the cell lines for this product been tested for contaminants? How to ensure the purity of cell lines?
A: Yes, our Luc/GFP Reporter Cell Line-NCI-N87 has undergone rigorous contaminant testing, including detection of common contaminants such as mycoplasma and bacteria. We use methods such as PCR and cell culture testing to ensure the purity of our cell lines. Our strict quality control procedures ensure that each batch of cell lines meets high standards of purity.
Ask a Question
Customer Reviews
Technical support
During cell culture, this Luc/GFP Reporter Cell Line-NCI-N87 showed amazing stability. The cells remained stable during growth, and there were no fluctuations in gene expression. I used GFP fluorescence and luciferase activity measurement systems for real-time monitoring, and the results were as reliable as ever, with almost no deviation. The supplier's service is also very good, providing detailed instructions and technical support. This gives me great peace of mind when studying gene expression and biological function. All in all, this product has greatly improved my research efficiency.
Fast shipping
I have been using this Luc/GFP Reporter Cell Line-NCI-N87 for several months and I am really satisfied with it. The cells grew well in culture, and the gene expression results were very consistent from experiment to experiment. Especially when observing GFP fluorescence, you can clearly see the gene expression inside the cell, which is very intuitive. The supplier's delivery was also very fast and the packaging was very tight without any damage. This cell line makes my research on gastric cancer more convenient and it is highly recommended.
United Kingdom
07/13/2022
Excellent after-sales service
I recently did some experiments with Luc/GFP Reporter Cell Line-NCI-N87, and the results exceeded expectations. The growth status of the cells is very good, and there is almost no contamination. Moreover, when monitoring gene expression in real-time, the signals of GFP and luciferase are very clear, which is very helpful for my data analysis. The after-sales service provided by the supplier is also very timely and professional, allowing me to quickly solve any problems I encountered during use. Very satisfied with this purchasing experience.
United Kingdom
03/15/2022
Write a Review